Enterprise

Pearl Health raises $110M, reaches profitability in value-based care

The Medicare-focused health tech company projects $500 million in healthcare savings while tripling its patient base through 2026.

Omega Editorial· July 8, 2026· 3 min read

Pearl Health announced a $110 million capital raise to expand its AI platform for managing Medicare patient care, marking a significant milestone as one of the few healthcare technology companies to reach profitability while maintaining aggressive growth.

The financing includes $50 million in equity led by Andreessen Horowitz, with participation from Viking Global Investors, AlleyCorp, and Ulysses Capital, plus a $60 million debt facility from Trinity Capital. The company reached profitability in 2025, according to details first reported in a company announcement.

Financial performance and scale

Pearl Health currently manages approximately $3.6 billion in annualized medical spending, up from $2.4 billion the previous year and $1.6 billion the year before. The company supports more than 10,000 providers across 40 states, serving over 250,000 Medicare beneficiaries through health systems including University of Vermont Health and MDX Hawaii.

The company projects it will generate $500 million in gross healthcare system savings while tripling its patient base from 2024 levels through the end of 2026.

Why it matters

As Medicare costs exceed $1 trillion annually for more than 70 million beneficiaries, healthcare reimbursement is increasingly shifting from fee-for-service to outcomes-based models. Pearl Health's profitability while scaling demonstrates that technology-driven risk management can succeed financially where many value-based care initiatives have struggled. The company's ability to deliver measurable savings without requiring providers to expand clinical workforces addresses a critical barrier to adoption in an industry facing persistent labor shortages.

Platform capabilities

Pearl's AI platform helps providers predict and manage patient risk, orchestrate clinical workflows, and automate interventions before health issues escalate into costly emergencies. The company is expanding its Performance Intelligence tools to give population health leaders AI-driven, chat-enabled insights on total cost of care, quality metrics, and utilization patterns.

The platform is also developing Care Orchestration AI agents to automate administrative tasks including annual wellness visit scheduling, post-discharge follow-ups, and care management outreach.

Strategic expansion

The new capital will fund Pearl's expansion into Medicare Advantage, enterprise health system and payer partnerships, and new risk-sharing arrangements. "Pearl was founded on a simple belief: healthcare should reward keeping people healthy, not just treating them when they are sick," said Michael Kopko, co-founder and CEO of Pearl Health.

Vineeta Agarwala, a general partner at Andreessen Horowitz, noted that Pearl has demonstrated the ability to manage risk across large patient populations in diverse care settings while generating meaningful savings and supporting a sustainable business model at scale.

Pearl Health was founded in 2020 and the funding details were first reported by the company.

#value-based care#medicare#healthcare ai#andreessen horowitz#health tech funding#population health

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 4 min read

Dr. Martens Rebuilt Customer Service From Scratch After Years of Decline

The footwear brand consolidated fragmented systems across regions onto Salesforce and AWS, reversing a three-year slide in customer satisfaction within months.

Via Automation Watch · Sep 24, 2026
Enterprise· 4 min read

AI Coding Tools Added $942M to Hospital Bills Without Care Changes

Blue Cross Blue Shield Association analysis finds hospitals using automation to classify more cases as complex, driving up costs with no documented increase in treatment intensity.

Via AI Watch · Sep 24, 2026
Enterprise· 4 min read

AI Clinical Trial Endpoints Fail at Scale Without Data Harmonization

Analysis of over one million patient screenings reveals that AI validation in single sites masks critical performance drift across multi-site deployments.

Via AI Watch · Sep 24, 2026